(S (NP (NP (DT The) (JJ novel) (NN nature)) (PP (IN of) (NP (NP (NNP SARS) (HYPH -) (NNP CoV)) (HYPH -) (NP (CD 2))))) (VP (VBZ calls) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ efficient) (NML (ADJP (FW de) (FW novo)) (NN drug) (NN design)) (NNS approaches)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (NP (NP (DT an) (NML (NML (NN end)) (HYPH -) (PP (IN to) (HYPH -) (NP (NN end)))) (NN framework)) (, ,) (VP (VBN named) (NP (NNP CogMol)))) (-LRB- -LRB-) (VP (VBN Controlled) (NP (NP (NNP Generation)) (PP (IN of) (NP (NNPS Molecules))))) (-RRB- -RRB-)) (, ,) (PP (IN for) (S (VP (VBG designing) (NP (NP (JJ new) (ADJP (NN drug) (HYPH -) (JJ like)) (JJ small) (NNS molecules)) (VP (VBG targeting) (NP (NP (JJ novel) (JJ viral) (NN proteins)) (PP (IN with) (NP (ADJP (ADJP (JJ high) (NN affinity)) (CC and) (ADJP (IN off) (HYPH -) (NN target))) (NN selectivity))))))))))) (. .))
(S (NP (NNP CogMol)) (VP (VBZ combines) (SBAR (S (NP (NP (JJ adaptive) (NN pre-training)) (PP (IN of) (NP (DT a) (JJ molecular)))) (VP (VBZ SMILES) (NP (NP (NNP Variational) (NNP Autoencoder) (-LRB- -LRB-) (NNP VAE) (-RRB- -RRB-)) (CC and) (NP (NP (DT an) (JJ efficient) (ADJP (JJ multi-attribute) (VBN controlled)) (NN sampling) (NN scheme)) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (NN guidance)) (PP (IN from) (NP (NP (NN attribute) (NNS predictors)) (VP (VBN trained) (PP (IN on) (NP (NN latent) (NNS features))))))))))))))) (. .))
(S (S (VP (TO To) (VP (VB generate) (NP (ADJP (JJ novel) (CC and) (JJ optimal)) (ADJP (NN drug) (HYPH -) (JJ like)) (NNS molecules)) (PP (IN for) (NP (JJ unseen) (JJ viral) (NNS targets)))))) (, ,) (NP (NNP CogMol)) (VP (VBZ leverages) (SBAR (S (S (NP (NP (DT a) (NML (NN protein) (HYPH -) (NN molecule)) (NML (NN binding) (NN affinity)) (NN predictor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN trained) (S (VP (VBG using)))))))) (VP (VBZ SMILES) (NP (NNP VAE) (NNS embeddings)))) (CC and) (S (NP (NML (NN protein) (NN sequence)) (NNS embeddings)) (VP (VBD learned) (VP (VBN unsupervised) (PP (IN from) (NP (DT a) (JJ large) (NN corpus))))))))) (. .))
(S (NP (NNP CogMol) (NN framework)) (VP (VBZ is) (VP (VBN applied) (PP (IN to) (NP (CD three))) (NP (NP (NP (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (CD 2)) (NP (NN target) (NN proteins))) (: :) (NP (NP (JJ main) (NN protease)) (, ,) (NP (NP (ADJP (NN receptor) (HYPH -) (VBG binding)) (NN domain)) (PP (IN of) (NP (DT the) (NN spike) (NN protein))))) (, ,) (CC and) (NP (JJ non-structural) (NML (NN protein) (CD 9)) (NN replicase))))) (. .))
(S (NP (DT The) (ADJP (VBN generated)) (NNS candidates)) (VP (VBP are) (ADJP (JJ novel) (PP (IN at) (NP (DT both) (ADJP (JJ molecular) (CC and) (JJ chemical)) (NN scaffold) (NNS levels)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN to) (NP (DT the) (NN training) (NNS data))))))) (. .))
(S (NP (NNP CogMol)) (ADVP (RB also)) (VP (VBZ includes) (NP (NN insilico) (NN screening)) (PP (IN for) (S (VP (VBG assessing) (NP (NP (NP (NN toxicity)) (PP (IN of) (NP (NN parent) (NNS molecules)))) (CC and) (NP (NP (PRP$ their) (NNS metabolites)) (PP (IN with) (NP (DT a) (NML (S (VP (VB multi-task) (NP (NN toxicity))))) (NN classifier)))) (, ,) (NP (NP (JJ synthetic) (NN feasibility)) (PP (IN with) (NP (DT a) (NN chemical) (NN retrosynthesis) (NN predictor)))) (, ,) (CC and) (NP (NP (NN target) (NN structure)) (VP (VBG binding) (PP (IN with) (NP (NN docking) (NNS simulations)))))))))) (. .))
(S (NP (NN Docking)) (VP (VBZ reveals) (NP (NP (JJ favorable) (NN binding)) (PP (IN of) (S (VP (VBN generated) (NP (NNS molecules)) (PP (IN to) (NP (DT the) (NN target) (NN protein) (NN structure))) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (QP (CD 87) (HYPH -) (CD 95)) (NN %)) (PP (IN of) (NP (NML (JJ high) (NN affinity)) (NNS molecules)))) (VP (VBD showed) (S (VP (VBG docking) (NP (NP (JJ free) (NN energy)) (-LRB- <) (NP (NP (CD -6) (NN kcal)) (PP (SYM /) (NP (NN mol))))))))))))))) (. .))
(S (SBAR (WHADVP (WRB When)) (S (VP (VBN compared) (PP (IN to) (NP (VBN approved) (NNS drugs)))))) (, ,) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (VBN designed) (NNS compounds)))) (VP (VBP show) (NP (NP (JJ low) (NN parent) (NN molecule)) (CC and) (NP (NN metabolite) (NN toxicity)) (CC and) (NP (JJ high) (JJ synthetic) (NN feasibility)))) (. .))
(S (PP (IN In) (NP (NN summary))) (, ,) (NP (NNP CogMol)) (VP (VP (VBZ handles) (NP (NP (JJ multi-constraint) (NN design)) (PP (IN of) (NP (NP (JJ synthesizable) (, ,) (ADJP (JJ low) (HYPH -) (JJ toxic)) (, ,) (ADJP (NN drug) (HYPH -) (JJ like)) (NNS molecules)) (PP (IN with) (NP (JJ high) (NN target) (NN specificity) (CC and) (NN selectivity))))))) (, ,) (CC and) (VP (VBZ does) (RB not) (VP (VB need) (NP (NP (ADJP (NN target) (HYPH -) (JJ dependent)) (JJ fine) (HYPH -) (NN tuning)) (PP (IN of) (NP (NP (DT the) (NN framework)) (CC or) (NP (NN target) (NN structure) (NN information)))))))) (. .))
